The impact of COVID ‐19 on oral squamous cell carcinoma's diagnostic stage—A retrospective study

This is the authors' abstract. We don't add key points for this paper.

Objective The COVID‐19 pandemic has had an impact on patients' access to primary care services. A timely diagnosis of oral squamosa cell carcinoma is paramount. This study aims to quantify the pandemic's effect on tumor volume at the time of initial diagnosis. Materials and Methods In a retrospective study, all primarily diagnosed cancer patients between March 2018 and March 2022 were compiled; the TNM stage and the tumor volume were evaluated. Tumor volumes were calculated using pathology or radiology reports. Results In total, 162 newly diagnosed tumor cases were included in this study. Of these, 76 (46.9%) cases were allocated in the “pre‐COVID‐19” group and 86 (53.1%) in the “COVID‐19” group. Patients diagnosed during the “COVID‐19” period showed a significantly advanced T stage (p < 0.001) and larger mean tumor volumes (53.16 ± 73.55 cm3 vs. 39.89 ± 102.42 cm3; p = 0.002) when compared to the control group. Conclusion Tumor volume and T stage were significantly advanced in the “COVID‐19” group when compared to prepandemic data. We hypothesize that the postponement of routine dental check‐ups may explain this finding. Hence, dentists and primary care providers are encouraged to place particular emphasis on screening during routine check‐ups.